logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006 [see all tables in this series...]

Part (viii) Percentage distribution of all inpatient clients by primary drug for age at first use

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opiates15.534.153.25449.546.138.323126581166
Cocaine3.510.111.812.213.511.310.65.73271374
Stimulants19.123.213.710.28.36.66.85.26081527
Hypnotics and sedatives3.74.58.112.71721.431.552.52552447
Hallucinogens3.25.831.81.30.40.80135490
Volatile substances5.91.30.40.20.20.40056122
Cannabis 48.120.197.68.310.59.15.26770812
Other substances 10.90.91.31.93.338.43931324
Total526115669682428741507725397383336404762

Notes:

 Countries reporting data: BG, CZ, DK, DE, IE, EL, FR, CY, LV, LU, AT, RO, SK, FI, SE, TR. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-109 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2007 — Table TDI — inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008